Literature DB >> 1631867

Leiomyosarcoma of the pulmonary hilar vessels.

C R Berney1, B Roche, A M Kurt, A Spiliopoulos, R Mégevand.   

Abstract

Leiomyosarcomas are uncommon tumors. They have a predilection for deep soft tissues, with a rare group arising in medium-sized or large veins, far less frequently in arteries. We report a case of a 63-year-old man, with an enlarging mass located in the left pulmonary hilar region which was discovered on a routine chest radiograph. Cytology of the sputum and bronchoscopic biopsies did not reveal any malignant cells. Over 5 months observation, there was a clear progression of the mass, and the patient finally underwent a left pneumonectomy which allowed the diagnosis of an intravascular leiomyosarcoma partially destroying major arteries and veins in the hilar region. A review of the literature reveals 67 cases of leiomyosarcoma involving the pulmonary artery. None of these cases had an associated venous pathology. The disease is found mainly in adult women. Clinical diagnosis is very difficult because most of the cases have no specific clinical signs; the major differential diagnosis is that of pulmonary thrombo-embolism. Prognosis depends on histological degree of the tumor and extent of the disease, metastases occur mainly in the liver, lung, and brain and less frequently in regional lymph nodes. Treatment is always surgical, chemotherapy is ineffective and the effectiveness of radiotherapy depends on the total dose of irradiation. Sarcomas of hilar blood vessels have a very poor prognosis with a one year survival estimated, from the onset of symptoms, at 20%.

Entities:  

Mesh:

Year:  1992        PMID: 1631867     DOI: 10.1055/s-2007-1020111

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  1 in total

1.  When a pulmonary embolism is not a pulmonary embolism: a rare case of primary pulmonary leiomyosarcoma.

Authors:  Nargiz Muganlinskaya; Amanda Guzman; Chanukya Dahagam; Stephen R Selinger
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.